Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.74
Delayed Data
As of 3:10pm ET
 +0.015 / +0.19%
Today’s Change
6.44
Today|||52-Week Range
9.88
-9.74%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.72
Today’s open7.78
Day’s range7.66 - 7.78
Volume82,377
Average volume (3 months)278,740
Market cap$608.5M
Dividend yield--
Data as of 3:10pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+24.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp+0.06+0.54%
NTRANatera Inc+0.07+0.79%
ENZEnzo Biochem Inc-0.11-1.32%
PTIProteostasis Therape...-0.11-0.99%
Data as of 3:23pm ET, 03/30/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs